vs
AeroVironment Inc（AVAV）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是AeroVironment Inc的1.0倍（$493.8M vs $472.5M），Pediatrix Medical Group, Inc.净利率更高（6.8% vs -3.6%，领先10.4%），AeroVironment Inc同比增速更快（181.9% vs -1.7%），过去两年AeroVironment Inc的营收复合增速更高（59.1% vs -0.1%）
AeroVironment是1971年由人力飞机设计师保罗·麦克里迪创立的美国国防科技企业，总部位于弗吉尼亚州阿灵顿，专注于自主系统、反无人机系统及航天系统的研发制造，为美国国防部及多国军方供应渡鸦、弹簧刀、黄蜂、美洲狮等系列中小型无人机产品。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
AVAV vs MD — 直观对比
营收规模更大
MD
是对方的1.0倍
$472.5M
营收增速更快
AVAV
高出183.6%
-1.7%
净利率更高
MD
高出10.4%
-3.6%
两年增速更快
AVAV
近两年复合增速
-0.1%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $472.5M | $493.8M |
| 净利润 | $-17.1M | $33.7M |
| 毛利率 | 22.0% | — |
| 营业利润率 | -6.4% | 9.9% |
| 净利率 | -3.6% | 6.8% |
| 营收同比 | 181.9% | -1.7% |
| 净利润同比 | -875.1% | 10.5% |
| 每股收益（稀释后） | $-0.34 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVAVMD
| Q4 25 | $472.5M | $493.8M | ||
| Q3 25 | $454.7M | $492.9M | ||
| Q2 25 | $275.1M | $468.8M | ||
| Q1 25 | $167.6M | $458.4M | ||
| Q4 24 | $188.5M | $502.4M | ||
| Q3 24 | $189.5M | $511.2M | ||
| Q2 24 | $197.0M | $504.3M | ||
| Q1 24 | $186.6M | $495.1M |
净利润AVAVMD
| Q4 25 | $-17.1M | $33.7M | ||
| Q3 25 | $-67.4M | $71.7M | ||
| Q2 25 | $16.7M | $39.3M | ||
| Q1 25 | $-1.8M | $20.7M | ||
| Q4 24 | $7.5M | $30.5M | ||
| Q3 24 | $21.2M | $19.4M | ||
| Q2 24 | $6.0M | $-153.0M | ||
| Q1 24 | $13.9M | $4.0M |
毛利率AVAVMD
| Q4 25 | 22.0% | — | ||
| Q3 25 | 20.9% | — | ||
| Q2 25 | 36.5% | — | ||
| Q1 25 | 37.7% | — | ||
| Q4 24 | 39.1% | — | ||
| Q3 24 | 43.0% | — | ||
| Q2 24 | 38.4% | — | ||
| Q1 24 | 36.1% | — |
营业利润率AVAVMD
| Q4 25 | -6.4% | 9.9% | ||
| Q3 25 | -15.2% | 13.8% | ||
| Q2 25 | 5.0% | 12.8% | ||
| Q1 25 | -1.8% | 7.0% | ||
| Q4 24 | 3.7% | 7.8% | ||
| Q3 24 | 12.2% | 6.6% | ||
| Q2 24 | 3.0% | -31.3% | ||
| Q1 24 | 7.7% | 3.2% |
净利率AVAVMD
| Q4 25 | -3.6% | 6.8% | ||
| Q3 25 | -14.8% | 14.5% | ||
| Q2 25 | 6.1% | 8.4% | ||
| Q1 25 | -1.0% | 4.5% | ||
| Q4 24 | 4.0% | 6.1% | ||
| Q3 24 | 11.2% | 3.8% | ||
| Q2 24 | 3.1% | -30.3% | ||
| Q1 24 | 7.4% | 0.8% |
每股收益（稀释后）AVAVMD
| Q4 25 | $-0.34 | $0.40 | ||
| Q3 25 | $-1.44 | $0.84 | ||
| Q2 25 | $0.59 | $0.46 | ||
| Q1 25 | $-0.06 | $0.24 | ||
| Q4 24 | $0.27 | $0.37 | ||
| Q3 24 | $0.75 | $0.23 | ||
| Q2 24 | $0.18 | $-1.84 | ||
| Q1 24 | $0.50 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $588.5M | $375.2M |
| 总债务越低越好 | $747.5M | $570.5M |
| 股东权益账面价值 | $4.4B | $865.9M |
| 总资产 | $5.6B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资AVAVMD
| Q4 25 | $588.5M | $375.2M | ||
| Q3 25 | $685.8M | $340.1M | ||
| Q2 25 | $40.9M | $224.7M | ||
| Q1 25 | $47.0M | $99.0M | ||
| Q4 24 | $69.0M | $229.9M | ||
| Q3 24 | $81.2M | $103.8M | ||
| Q2 24 | $73.3M | $19.4M | ||
| Q1 24 | $107.7M | $8.0M |
总债务AVAVMD
| Q4 25 | $747.5M | $570.5M | ||
| Q3 25 | $747.5M | $577.2M | ||
| Q2 25 | $30.0M | $583.9M | ||
| Q1 25 | $25.0M | $590.5M | ||
| Q4 24 | $15.0M | $597.1M | ||
| Q3 24 | $17.5M | — | ||
| Q2 24 | $28.0M | — | ||
| Q1 24 | $40.0M | — |
股东权益AVAVMD
| Q4 25 | $4.4B | $865.9M | ||
| Q3 25 | $4.4B | $890.7M | ||
| Q2 25 | $886.5M | $833.8M | ||
| Q1 25 | $861.1M | $789.2M | ||
| Q4 24 | $858.4M | $764.9M | ||
| Q3 24 | $845.5M | $732.5M | ||
| Q2 24 | $822.7M | $706.5M | ||
| Q1 24 | $813.0M | $856.2M |
总资产AVAVMD
| Q4 25 | $5.6B | $2.2B | ||
| Q3 25 | $5.6B | $2.2B | ||
| Q2 25 | $1.1B | $2.1B | ||
| Q1 25 | $1.0B | $2.0B | ||
| Q4 24 | $1.0B | $2.2B | ||
| Q3 24 | $999.2M | $2.1B | ||
| Q2 24 | $1.0B | $2.0B | ||
| Q1 24 | $980.3M | $2.2B |
负债/权益比AVAVMD
| Q4 25 | 0.17× | 0.66× | ||
| Q3 25 | 0.17× | 0.65× | ||
| Q2 25 | 0.03× | 0.70× | ||
| Q1 25 | 0.03× | 0.75× | ||
| Q4 24 | 0.02× | 0.78× | ||
| Q3 24 | 0.02× | — | ||
| Q2 24 | 0.03× | — | ||
| Q1 24 | 0.05× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-45.1M | $114.1M |
| 自由现金流经营现金流 - 资本支出 | $-55.9M | — |
| 自由现金流率自由现金流/营收 | -11.8% | — |
| 资本支出强度资本支出/营收 | 2.3% | — |
| 现金转化率经营现金流/净利润 | — | 3.39× |
| 过去12个月自由现金流最近4个季度 | $-240.7M | — |
8季度趋势，按日历期对齐
经营现金流AVAVMD
| Q4 25 | $-45.1M | $114.1M | ||
| Q3 25 | $-123.7M | $137.3M | ||
| Q2 25 | $-264.0K | $137.2M | ||
| Q1 25 | $-25.8M | $-117.5M | ||
| Q4 24 | $-3.6M | $133.0M | ||
| Q3 24 | $28.4M | $91.8M | ||
| Q2 24 | $-11.7M | $107.0M | ||
| Q1 24 | $52.6M | $-125.2M |
自由现金流AVAVMD
| Q4 25 | $-55.9M | — | ||
| Q3 25 | $-146.5M | — | ||
| Q2 25 | $-8.8M | — | ||
| Q1 25 | $-29.6M | — | ||
| Q4 24 | $-8.7M | — | ||
| Q3 24 | $22.9M | — | ||
| Q2 24 | $-20.8M | — | ||
| Q1 24 | $48.8M | — |
自由现金流率AVAVMD
| Q4 25 | -11.8% | — | ||
| Q3 25 | -32.2% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -17.7% | — | ||
| Q4 24 | -4.6% | — | ||
| Q3 24 | 12.1% | — | ||
| Q2 24 | -10.5% | — | ||
| Q1 24 | 26.1% | — |
资本支出强度AVAVMD
| Q4 25 | 2.3% | — | ||
| Q3 25 | 5.0% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 2.3% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 2.9% | — | ||
| Q2 24 | 4.6% | — | ||
| Q1 24 | 2.0% | — |
现金转化率AVAVMD
| Q4 25 | — | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | -0.02× | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | -0.48× | 4.36× | ||
| Q3 24 | 1.34× | 4.72× | ||
| Q2 24 | -1.93× | — | ||
| Q1 24 | 3.79× | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVAV
| Services | $130.2M | 28% |
| Cost Plus | $95.8M | 20% |
| Uncrewed Aircraft Systems | $89.8M | 19% |
| Space And Directed Energy | $53.2M | 11% |
| Non U.s.Government | $42.2M | 9% |
| TM | $31.9M | 7% |
| Other | $30.7M | 7% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
